🧬 Rafael Rosengarten - Part 4 | Lessons in Scaling a Biotech Startup | Using AI to Transform Cancer Diagnostics | The Genialis Supermodel & krasID

🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success.

🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸

🔗 Get your unique referral link here: refer.excedr.com/ZTHETY. 

Part 4 of 4: My guest today is Rafael Rosengarten, CEO and Co-Founder of Genialis, the RNA biomarker company. Genialis is reimagining biomarkers for every target, drug, and patient using a combination of precision oncology, RNA, and AI.

Rafael, a biomedical research veteran, combines academic excellence with industry innovation. A Dartmouth graduate with a Yale doctorate, he conducted postdoctoral research at Lawrence Berkeley National Laboratory, where he co-invented the j5 DNA assembly tool. As co-founder of the Alliance for AI in Healthcare, he advocates for responsible AI integration in medicine, drawing from his extensive background in evolution, immunology, bioengineering, and genetics.

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening!

https://www.genialis.com/ 

LinkedIn: https://www.linkedin.com/company/excedr/ 

Youtube: https://www.youtube.com/@excedr 

Instagram: https://www.instagram.com/excedr_inc 

Twitter: https://twitter.com/ExcedrInc 

Facebook: https://www.facebook.com/excedr 

TikTok: https://www.tiktok.com/@excedr 

Podcast Website: https://www.thebiotechstartupspodcast.com/ 

Genialis: https://www.genialis.com/
Taiwania Capital: https://www.taiwaniacapital.com/
Debiopharm Innovation Fund: https://www.debiopharm.com/innovation-fund/

Genialis krasID: https://www.genialis.com/krasid/

Genialis Supermodel: https://www.genialis.com/supermodel/

How to Bootstrap a Biotech: https://www.excedr.com/resources/how-to-bootstrap-biotech-startup

Biotech Funding Options: https://www.excedr.com/resources/biotech-startup-funding-options

Top VCs in Biotech: https://www.excedr.com/blog/top-vc-firms-for-biotech

AI in Cancer Diagnostics: https://www.frontiersin.org/articles/10.3389/fonc.2020.588221/full

Predictive Biomarkers in Oncology: https://oncologypro.esmo.org/education-library/esmo-books/esmo-handbooks/translational-research/predictive-biomarkers

How Biotech Partnerships Support Research: https://www.excedr.com/blog/how-biotech-partnerships-support-research

Cheng Wu (Founding Partner, Taiwania Capital): https://www.linkedin.com/in/cheng-wu-4614a8a/

Tiasha Stanković (COO, Head of People at Genialis): https://www.linkedin.com/in/tjasakk/?originalSubdomain=si

Luka Ausec (Chief Discovery Officer at Genialis): https://www.linkedin.com/in/luka-ausec-378009150/

Miha Štajdohar (Co-founder, CTO at Genialis): https://www.linkedin.com/in/mstajdohar/

Marinka Zitnik (AI Researcher, Associate Professor of Bioinformatics): https://dbmi.hms.harvard.edu/people/marinka-zitnik

00:00 Intro

02:04 Scaling Genialis during COVID-19 and adapting as CEO

04:27 How pivotal clients influence a startup’s growth path

07:15 Addressing critical mistakes in clinical data pipelines

09:43 Redefining Genialis’ mission and fostering strong culture

12:19 Adapting to remote work while reinforcing team values

14:57 Raising Series A funding amid challenging market conditions

20:50 The importance of team culture and resilience

25:37 The Genialis supermodel and its impact on oncology AI

29:12 Two-year vision for Genialis and its three pillars

32:59 Closing questions and advice for entrepreneurs

38:59 Outro

The Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.